Charles G. Drake
- Oncology top 0.02%
- Immunology top 0.02%
- Pulmonary and Respiratory Medicine top 0.05%
- Neurology top 0.02%
- Molecular Biology top 0.5%
- Co-authors
- Drew M. PardollSuzanne L. TopalianSydney J. PeerlessAllan J. FoxEvan J. LipsonDario A.A. VignaliAngelo M. De MarzoFernando Viñuela
- Topics
- Cancer Immunotherapy and Biomarkers (230 papers)Immunotherapy and Immune Responses (138 papers)Prostate Cancer Treatment and Research (109 papers)
- Cited by
- ImmunologyOncologyNeurology
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Charles G. Drake
478 papers receiving 39.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Oncology 18.6k
- Immunology 16.0k
- Pulmonary and Respiratory Medicine 10.0k
- Neurology 9.2k
- Molecular Biology 6.1k
Countries citing papers authored by Charles G. Drake
This map shows the geographic impact of Charles G. Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles G. Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles G. Drake more than expected).
Fields of papers citing papers by Charles G. Drake
This network shows the impact of papers produced by Charles G. Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles G. Drake. The network helps show where Charles G. Drake may publish in the future.
Co-authorship network of co-authors of Charles G. Drake
This figure shows the co-authorship network connecting the top 25 collaborators of Charles G. Drake. A scholar is included among the top collaborators of Charles G. Drake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles G. Drake. Charles G. Drake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 39 | |
| 2 | 7 | |
| 3 | 35 | |
| 4 | 26 | |
| 5 | 67 | |
| 6 | 56 | |
| 7 | 28 | |
| 8 | 166 | |
| 9 | 133 | |
| 10 | 41 | |
| 11 | 60 | |
| 12 | 101 | |
| 13 | 54 | |
| 14 | 34 | |
| 15 | Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigenbreakdown → | 510 |
| 16 | 18 | |
| 17 | Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinomabreakdown → | 602 |
| 18 | 434 | |
| 19 | 122 | |
| 20 | 245 |
About Charles G. Drake
Charles G. Drake is a scholar working on Oncology, Immunology and Neurology, having authored 490 papers that have together received 40.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (230 papers), Immunotherapy and Immune Responses (138 papers) and Prostate Cancer Treatment and Research (109 papers). The work is most often cited by research in Immunology (16.0k citations), Oncology (18.6k citations) and Neurology (9.2k citations). Charles G. Drake has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Drew M. Pardoll, Suzanne L. Topalian, Sydney J. Peerless, Allan J. Fox, Evan J. Lipson, Dario A.A. Vignali, Angelo M. De Marzo, Fernando Viñuela, Robert A. Anders and Julie R. Brahmer. Their work appears in journals such as Science, New England Journal of Medicine and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.